Actelion Settles Row Over Giving Drugs To Generics Makers

Law360, Los Angeles (February 28, 2014, 7:07 PM EST) -- Actelion Pharmaceuticals Ltd. reached a settlement with generic-drug makers in its quest for a New Jersey federal court to confirm antitrust laws don’t require the company to supply its patented blood pressure drug Tracleer for generics development, according to an order dismissing the case Friday.

U.S. District Judge Noel L. Hillman's dismissal leaves open the option for the parties to re-enter litigation if the deal isn’t consummated within 60 days. The settlement's terms were not disclosed.

When Actelion's suit was filed in September 2012, it heralded...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.